Expression of apolipoprotein C-IV is regulated by Ku antigen/peroxisome proliferator-activated receptor gamma complex and correlates with liver steatosis.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Hepatology

• Publication date

  2008-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jhep.2008.06.029PMID 18809223PMCID PMC2644636
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteins.

  2006cited by this paper
• Hepatitis C virus molecular clones: from cDNA to infectious virus particles in cell culture.

  2006cited by this paper
• Peroxisome Proliferator-activated Receptor-γ1 Is Dephosphorylated and Degraded during BAY 11-7085-induced Synovial Fibroblast Apoptosis*

  2006cited by this paper
• Exploration of global gene expression in human liver steatosis by high-density oligonucleotide microarray

  2006cited by this paper
• Hepatitis C virus core protein stimulates hepatocyte growth: Correlation with upregulation of wnt‐1 expression

  2005cited by this paper
• Phosphorylation of PPARs: from molecular characterization to physiological relevance.

  2005cited by this paper
• An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation.

  2005cited by this paper
• Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease.

  2004cited by this paper
• Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN

  2003cited by this paper
• Liver Peroxisome Proliferator-activated Receptor γ Contributes to Hepatic Steatosis, Triglyceride Clearance, and Regulation of Body Fat Mass*

  2003cited by this paper
• Modulation of Retinoid Signaling by a Cytoplasmic Viral Protein via Sequestration of Sp110b, a Potent Transcriptional Corepressor of Retinoic Acid Receptor, from the Nucleus

  2003cited by this paper
• Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets

  2002cited by this paper
• PROMO: detection of known transcription regulatory elements using species-tailored searches

  2002cited by this paper
• Nonalcoholic fatty liver disease.

  2002cited by this paper
• Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus.

  2002cited by this paper
• Dimerization, translocation and localization of Ku70 and Ku80 proteins.

  2002cited by this paper
• Interaction of hepatitis C virus core protein with retinoid X receptor α modulates its transcriptional activity

  2002cited by this paper
• Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method.

  2002cited by this paper
• Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication

  2002cited by this paper
• Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral‐related steatosis

  2002cited by this paper
• Expression of liver steatosis in hepatitis C virus infection and pattern of response to alpha-interferon.

  2001cited by this paper
• Expression of liver steatosis in hepatitis C virus infection and pattern of response to α-interferon

  2001cited by this paper
• Transcriptional regulation of the human apolipoprotein genes.

  2001cited by this paper
• Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators.

  2000cited by this paper
• Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates

  1999cited by this paper
• Carboxypeptidase D Is an Avian Hepatitis B Virus Receptor

  1999cited by this paper
• Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets.

  1997cited by this paper
• Hepatitis C virus core protein induces hepatic steatosis in transgenic mice.

  1997cited by this paper
• Transcriptional regulation of the human apolipoprotein genes.

  1991cited by this paper
• Nonalcoholic fatty liver disease.

  1986cited by this paper

• Ovarian somatic tissue rejuvenates circulating apolipoproteins and promotes cognitive health in postreproductive female mice.

  2025cites this paper
• Chronic alcohol feeding alters lymph and plasma proteome in a rodent model.

  2023cites this paper
• Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies

  2022cites this paper
• The NRF2-dependent transcriptional axis, XRCC5/hTERT drives tumor progression and 5-Fu insensitivity in hepatocellular carcinoma

  2021cites this paper
• Plasma Proteomics Characteristics of Subclinical Vitamin E Deficiency of Dairy Cows During Early Lactation

  2021cites this paper
• Mechanisms of Genome Maintenance in Plants: Playing It Safe With Breaks and Bumps

  2021cites this paper
• NEAT1/hsa-miR-372-3p axis participates in rapamycin-induced lipid metabolic disorder.

  2021cites this paper
• Chicory root flour – A functional food with potential multiple health benefits evaluated in a mice model

  2020cites this paper
• Apolipoprotein C1: Its Pleiotropic Effects in Lipid Metabolism and Beyond

  2019cites this paper
• Current Progress and Challenges in the Development of a Hepatitis C Virus Vaccine

  2019cites this paper
• Hepatitis C Virus (HCV)–Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design

  2018cites this paper
• Xi-Dai Long, Zhou-Ximao Long, Xiao-Ying Huang, Jin-Guang Yao, Qiang Xia and Yan Deng

  2018cites this paper
• Hepatocarcinoma Angiogenesis and DNA Damage Repair Response: An Update

  2018cites this paper
• Chromatin association of XRCC5/6 in the absence of DNA damage depends on the XPE gene product DDB2

  2017cites this paper
• Steatotic and Steatohepatitic Hepatocellular Carcinomas and Related Neoplasms

  2016cites this paper
• Activated immune response in an inherited leukodystrophy disease caused by the loss of oligodendrocyte gap junctions.

  2015cites this paper
• Structure of HDL: particle subclasses and molecular components.

  2015cites this paper
• Modes-of-Action Related to Repeated Dose Toxicity: Tissue-Specific Biological Roles of PPARγ Ligand-Dependent Dysregulation in Nonalcoholic Fatty Liver Disease

  2014cites this paper
• Assessment of reproducibility in depletion and enrichment workflows for plasma proteomics using label‐free quantitative data‐independent LC‐MS

  2014cites this paper
• Biomarqueurs pour patients infectés par le hcv

  2013cites this paper
• Hepatitis C Virus, Cholesterol and Lipoproteins — Impact for the Viral Life Cycle and Pathogenesis of Liver Disease

  2013cites this paper
• Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III

  2012cites this paper
• DNA-PK, a Pharmacological Target in Cancer Chemotherapy and Radiotherapy?

  2011cites this paper
• Effects of Common and Rare Genetic Variants of Apolipoprotein C4 on HDL-Cholesterol Levels

  2011influential citation
• An adipocentric view of the development of insulin resistance

  2011cites this paper
• Sub-chronic administration of stable GIP analog in mice decreases serum LPL activity and body weight.

  2011cites this paper
• Ku proteins interact with activator protein-2 transcription factors and contribute to ERBB2 overexpression in breast cancer cell lines

  2009cites this paper
• Hepatitis C Virus, Cholesterol and Lipoproteins — Impact for the Hepatitis C Virus, Cholesterol and Lipoproteins — Impact for the Viral Life Cycle and Pathogenesis of Liver Disease Viral Life Cycle and Pathogenesis of Liver Disease

  year unknowncites this paper